510(k) K221664
K221664 is an FDA 510(k) premarket notification submitted by Aardvark Medical, Inc. for the device "CLEARinse CTS Specimen Collection and Transport System". The FDA issued a decision of Substantially Equivalent on Jul 3, 2023. The device falls under product code QBD (Microbial Nucleic Acid Storage And Stabilization Device), a Class II device regulated under 21 CFR 866.2950. Aardvark Medical, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jul 3, 2023
- Date Received
- Jun 8, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Microbial Nucleic Acid Storage And Stabilization Device
- Device Class
- Class II
- Regulation Number
- 866.2950
- Review Panel
- MI
- Submission Type
- 510(k)
Molecular transport media is a device intended for the stabilization and transportation of nucleic acids from unprocessed human samples suspected of containing infectious material.
Need the full FDA record for Aardvark Medical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.